Clinical observation on gefitinib in treatment of non-small cell lung cancer and related nursing care interventions

VernacularTitle:吉非替尼治疗晚期非小细胞肺癌的临床观察及护理
Author: Yuan ZHOU ¹ ; Xiuju SHI ; Xia MA
Author Information

1. 河北省唐山市人民医院呼吸科
Keywords: non-small cell lung cancer; gefitnib; skin rash; diarrhea
From: Journal of Clinical Medicine in Practice 2014;(22):38-40
CountryChina
Language:Chinese
Abstract: ABSTRACT:Objective To observe the clinical effects of and side reaction to gefitnib in treat-ment of non-small cell lung cancer (NSCLC),and to discuss related nursing interventions.Meth-ods A total of 110 NSCLC patients were administrated with gefitinib 250 mg per day.Response rate and side effects were observed regularly,and nursing experience was summarized after treat-ment.Results Overall response rate and disease control rate was 14.5% and 59%,respectively. Out of 110 patients,54 with skin rash,32 with diarrhea,14 with nausea and 13 with increased aminotransferase,but were reversible by nursing care.Conclusion Gefitnib shows effects in treat-ing NSCLC,and intensive nursing care is required to prevent side reactions.